2.19
+0.01(+0.46%)
Currency In USD
| Previous Close | 2.18 |
| Open | 2.17 |
| Day High | 2.25 |
| Day Low | 2.17 |
| 52-Week High | 8.27 |
| 52-Week Low | 1.72 |
| Volume | 47,431 |
| Average Volume | 93,569 |
| Market Cap | 4.38M |
| PE | -0.19 |
| EPS | -11.65 |
| Moving Average 50 Days | 2.31 |
| Moving Average 200 Days | 3 |
| Change | 0.01 |
If you invested $1000 in InMed Pharmaceuticals Inc. (INM) 10 years ago, it would be worth $1.03 as of September 29, 2025 at a share price of $2.19. Whereas If you bought $1000 worth of InMed Pharmaceuticals Inc. (INM) shares 5 years ago, it would be worth $1.25 as of September 29, 2025 at a share price of $2.19.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Newsfile
Sep 05, 2025 5:33 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for dise
InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025
Newsfile
Jul 28, 2025 11:00 AM GMT
Long-term INM-901 treatment in preclinical studies in advanced disease continues to show multi-modal activityVancouver, British Columbia--(Newsfile Corp. - July 28, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharma
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
Newsfile
Jun 27, 2025 11:00 AM GMT
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases